Get started
Author

Kentaro Ito

Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer
2020 · Yuta Adachi, Kentaro Ito, et al. · Clinical Cancer Research · 258
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L
2021 · Shinya Sakata, Kohei Otsubo, et al. · Cancer Science · 75
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)
2021 · Hiroyuki Yamaguchi, Kazushige Wakuda, et al. · Journal of Thoracic Oncology · 74
PDF
Sequential Therapy with Crizotinib and Alectinib in ALK -Rearranged Non–Small Cell Lung Cancer—A Multicenter Retrospective Study
2016 · Kentaro Ito, Osamu Hataji, et al. · Journal of Thoracic Oncology · 57
PDF
Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria
2019 · Tadashi Sakaguchi, Kentaro Ito, et al. · Respiratory Investigation · 48
A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903
2021 · K. Ito, M. Morise, et al. · ESMO Open · 47
Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease
2012 · Esteban Gabazza, Osamu Hataji, et al. · International Journal of COPD · 35
PDF
“Pseudoprogression” of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy
2016 · Kentaro Ito, Osamu Hataji, et al. · Journal of Thoracic Oncology · 34
PDF
Real‐world efficacy of atezolizumab in non‐small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti‐ PD ‐1 antibody
2021 · Naoki Furuya, Makoto Nishino, et al. · Thoracic Cancer · 33
PDF
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study
2021 · Kentaro Ito, Takeharu Yamanaka, et al. · European Journal of Cancer · 31
Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer
2024 · Kentaro Ito, Yuta Suzuki, et al. · JAMA Oncology · 28
PDF
Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study)
2023 · Atsushi Nakamura, Ou Yamaguchi, et al. · European Journal of Cancer · 25
The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis
2017 · Nobuyuki Horita, Akimichi Nagashima, et al. · Scientific Reports · 23
PDF
Comparison of the analytical performance between the O ncomine D x T arget T est and a conventional single gene test for epidermal growth factor receptor mutation in non‐small cell lung cancer
2020 · Tadashi Sakaguchi, Akemi Iketani, et al. · Thoracic Cancer · 22
PDF
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer
2018 · Atsushi Fujiwara, Masamichi Yoshida, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 22
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
2024 · Naoya Nishioka, Hisao Imai, et al. · Targeted Oncology · 21
PDF
Renal Injury during Long-Term Crizotinib Therapy
2018 · Taro Yasuma, Tetsu Kobayashi, et al. · International Journal of Molecular Sciences · 19
PDF
The clinical benefits of denosumab for prophylaxis of steroid-induced osteoporosis in patients with pulmonary disease
2017 · Shigeo Ishiguro, Kentaro Ito, et al. · Archives of Osteoporosis · 19
Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial
2023 · Reiko Matsuzawa, Masahiro Morise, et al. · EClinicalMedicine · 18
PDF
Use of Ultrathin Bronchoscope on a Need Basis Improves Diagnostic Yield of Difficult-to-Approach Pulmonary Lesions
2020 · Yoichi Nishii, Yuki Nakamura, et al. · Frontiers in Medicine · 18
PDF
Comparison of the analytical performance of the Oncomine dx target test focusing on bronchoscopic biopsy forceps size in non‐small cell lung cancer
2022 · Tadashi Sakaguchi, Yoichi Nishii, et al. · Thoracic Cancer · 17
Factors leading to failure to diagnose pulmonary malignant tumors using endobronchial ultrasound with guide sheath within the target lesion
2019 · Yoichi Nishii, Taro Yasuma, et al. · Respiratory Research · 17
PDF
Nintedanib Plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis
2024 · Satoshi Ikeda, Takashi Ogura, et al. · Annals of the American Thoracic Society · 16
Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non–Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice
2017 · Kentaro Ito, Yuta Suzuki, et al. · Clinical Lung Cancer · 16
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
2023 · Daichi Fujimoto, Satoru Miura, et al. · Scientific Reports · 15
PDF
Works count: 116
Citation count: 1,307
H-index: 18
I10-index: 37
Year
Topic
Type